Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Joint Pain

2-amino-5-phosphonovalerate has been researched along with Joint Pain in 1 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, GH1
Min, SS1
Seol, GH1
Lee, KS1
Han, H1
In Kim, Y1
Han, HC1

Other Studies

1 other study available for 2-amino-5-phosphonovalerate and Joint Pain

ArticleYear
Inhibition of the N-methyl-d-aspartate receptor unmasks the antinociception of endogenous opioids in the periphery.
    Pain, 2009, Volume: 143, Issue:3

    Topics: 2-Amino-5-phosphonovalerate; Analgesics, Opioid; Animals; Arthralgia; Arthritis; beta-Endorphin; Car

2009